soha News

Producing effective drug in order to improve the treatment of coronavirus disease (COVID-19) processes.

According to the public relations of Soha Pharmaceutical Company report:

        During the ongoing global pandemic of coronavirus disease (COVID-19), Soha in the direction of humanitarian duties as a Pharmaceutical Company tries to produce effective drug in order to improve the treatment of coronavirus disease (COVID-19) processes. Therefore, this company has produced Azithromycin 250 mg and 500 mg in capsule dosage form in the purpose of decreasing pain in coronavirus patients. In addition, currently available in distribution companies

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button